Posted by Michael Wonder on 12 Mar 2023
By cutting insulin prices, Eli Lilly avoids paying big Medicaid rebates
6 March 2023 - Eli Lilly would’ve had to pay Medicaid about $150 for each vial of insulin used in the program if it hadn’t dramatically cut the list prices for some of its older products this week.
The company was about to run into a Medicaid penalty for hiking the price of its drugs faster than the rate of inflation. Now that it plans to lower the list price of the insulin Humalog 70%, it won’t trigger that penalty.
